Republic Bancorp (RBCAA) Director Reports Purchase, 2,839.63 Shares Owned
Rhea-AI Filing Summary
Ravichandran Vidya, a director of Republic Bancorp Inc. (RBCAA), reported an insider purchase on 09/30/2025. The Form 4 shows a non-derivative acquisition of 159.17 shares of Class A common stock at a price of $72.25 per share, resulting in 2,839.63 shares beneficially owned following the transaction. The filing notes these shares reflect additional dividend equivalent rights accumulated since the last ownership report. The report was filed as a single reporting person filing and executed by an attorney-in-fact on 10/02/2025.
Positive
- Director purchase disclosed: Ravichandran Vidya acquired 159.17 Class A shares, increasing reported beneficial ownership to 2,839.63 shares
- Transparent disclosure: Filing includes explanatory note about dividend equivalent rights, clarifying changes since the last report
Negative
- None.
Insights
TL;DR: A routine director purchase was reported; amount appears modest relative to institutional levels and notes dividend-equivalent accruals.
The Form 4 documents a standard non-derivative acquisition by a director, showing 159.17 Class A shares purchased at $72.25 and 2,839.63 shares owned after the trade. The disclosure of "additional dividend equivalent rights" clarifies part of the change in beneficial ownership since the prior report. This filing is procedural and provides transparency on insider holdings; it does not disclose any derivative exercises, option grants, or other compensatory detail beyond the dividend-equivalent note.
TL;DR: Filing is a routine Section 16 disclosure by a director; no governance red flags or unusual transactions are evident.
The report identifies the reporting person as a director and shows a straightforward acquisition of Class A common stock on 09/30/2025. The signature block indicates the form was submitted via attorney-in-fact, which is common for insiders using delegated filing authority. The explanatory footnote specifies the change includes dividend-equivalent rights; no option exercises, sales, or dilutive events are reported here. Overall, the disclosure meets Section 16 transparency requirements without material governance concerns.